Astrana Health(DE:3AM)
€30.00-0.80 (-10.71%)
DE:3AM
Astrana Health financials statements
€30.00
At close:-0.80 (-10.71%)
Astrana Health (3AM) Ratios
0 Followers
Astrana Health Ratios
DE:3AM's free cash flow for Q3 2026 was $12.44M. For the 2026 fiscal year, DE:3AM's free cash flow was decreased by $-3.83M and operating cash flow was $16.27M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 |
| Quick Ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 |
| Cash Ratio | 0.70 | 0.79 | 1.34 | 1.94 | 2.03 |
| Solvency Ratio | 0.04 | 0.08 | 0.15 | 0.15 | 0.24 |
| Operating Cash Flow Ratio | 0.19 | 0.14 | 0.31 | 0.55 | 0.61 |
| Short-Term Operating Cash Flow Coverage | 2.39 | 5.57 | 3.50 | 132.68 | 90.17 |
| Net Current Asset Value | $ -797.01M | $ -202.23M | $ -61.09M | $ 20.46M | $ 47.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.35 | 0.34 | 0.24 | 0.23 |
| Debt-to-Equity Ratio | 1.38 | 0.66 | 0.52 | 0.42 | 0.45 |
| Debt-to-Capital Ratio | 0.58 | 0.40 | 0.34 | 0.30 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.56 | 0.37 | 0.30 | 0.27 | 0.29 |
| Financial Leverage Ratio | 2.85 | 1.90 | 1.52 | 1.78 | 1.94 |
| Debt Service Coverage Ratio | 1.22 | 2.61 | 2.58 | 8.34 | 11.17 |
| Interest Coverage Ratio | 1.57 | 2.70 | 5.25 | 13.16 | 18.20 |
| Debt to Market Cap | 0.85 | 0.29 | 0.15 | 0.15 | 0.06 |
| Interest Debt Per Share | 22.99 | 10.59 | 7.22 | 5.28 | 4.71 |
| Net Debt to EBITDA | 4.79 | 1.29 | 0.22 | -0.52 | -0.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.30% | 13.34% | 15.50% | 17.43% | 22.97% |
| EBIT Margin | 2.81% | 5.60% | 7.64% | 8.26% | 10.74% |
| EBITDA Margin | 4.25% | 6.97% | 8.92% | 9.80% | 13.01% |
| Operating Profit Margin | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% |
| Pretax Profit Margin | 1.24% | 3.97% | 6.48% | 7.57% | 10.05% |
| Net Profit Margin | 0.71% | 2.12% | 4.38% | 3.95% | 8.91% |
| Continuous Operations Profit Margin | 0.76% | 2.45% | 4.17% | 4.00% | 5.95% |
| Net Income Per EBT | 56.78% | 53.39% | 67.58% | 52.15% | 88.65% |
| EBT Per EBIT | 50.44% | 90.45% | 106.18% | 83.07% | 79.19% |
| Return on Assets (ROA) | 1.01% | 3.18% | 6.51% | 4.68% | 7.95% |
| Return on Equity (ROE) | 2.89% | 6.05% | 9.89% | 8.33% | 15.38% |
| Return on Capital Employed (ROCE) | 4.90% | 9.03% | 11.84% | 12.75% | 13.04% |
| Return on Invested Capital (ROIC) | 2.88% | 5.50% | 7.37% | 6.70% | 7.69% |
| Return on Tangible Assets | 2.07% | 5.28% | 10.42% | 7.28% | 12.81% |
| Earnings Yield | 1.85% | 2.87% | 3.35% | 3.39% | 2.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.81 | 6.26 | 9.39 | 9.56 | 7.79 |
| Payables Turnover | 64.36 | 116.24 | 129.11 | 90.20 | 108.13 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 33.69 | 43.40 | 31.11 | 8.87 | 11.28 |
| Asset Turnover | 1.43 | 1.50 | 1.49 | 1.18 | 0.89 |
| Working Capital Turnover Ratio | 12.22 | 7.89 | 5.31 | 4.02 | 3.02 |
| Cash Conversion Cycle | 41.08 | 55.13 | 36.06 | 34.15 | 43.46 |
| Days of Sales Outstanding | 46.76 | 58.27 | 38.89 | 38.20 | 46.84 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 5.67 | 3.14 | 2.83 | 4.05 | 3.38 |
| Operating Cycle | 46.76 | 58.27 | 38.89 | 38.20 | 46.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.34 | 1.09 | 1.46 | 1.83 | 1.60 |
| Free Cash Flow Per Share | 2.13 | 0.93 | 0.85 | 1.32 | 1.17 |
| Dividend Paid and CapEx Coverage Ratio | 6.37 | 4.33 | 0.75 | 2.22 | 1.40 |
| Capital Expenditure Coverage Ratio | 11.34 | 6.50 | 2.39 | 3.58 | 3.66 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.11 | 0.21 | 0.36 | 0.35 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.03 | 0.05 | 0.07 | 0.09 |
| Free Cash Flow Yield | 8.58% | 2.94% | 2.19% | 4.45% | 1.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 53.93 | 34.65 | 29.83 | 29.46 | 46.73 |
| Price-to-Sales (P/S) Ratio | 0.38 | 0.74 | 1.31 | 1.16 | 4.16 |
| Price-to-Book (P/B) Ratio | 1.56 | 2.11 | 2.95 | 2.45 | 7.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.65 | 34.04 | 45.63 | 22.48 | 63.01 |
| Price-to-Operating Cash Flow Ratio | 10.62 | 28.81 | 26.55 | 16.20 | 45.79 |
| Price-to-Earnings Growth (PEG) Ratio | -1.09 | -1.15 | 0.99 | -0.81 | 0.92 |
| Enterprise Value Multiple | 13.79 | 11.89 | 14.86 | 11.35 | 31.68 |
| Enterprise Value | 1.87B | 1.69B | 1.84B | 1.27B | 3.19B |
| EV to EBITDA | 13.79 | 11.89 | 14.86 | 11.35 | 31.68 |
| EV to Sales | 0.59 | 0.83 | 1.33 | 1.11 | 4.12 |
| EV to Free Cash Flow | 17.86 | 38.19 | 46.31 | 21.49 | 62.38 |
| EV to Operating Cash Flow | 16.29 | 32.32 | 26.95 | 15.49 | 45.33 |
| Tangible Book Value Per Share | -11.75 | -0.49 | 1.29 | 4.73 | 4.14 |
| Shareholders’ Equity Per Share | 15.88 | 14.95 | 13.15 | 12.06 | 10.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.39 | 0.38 | 0.36 | 0.47 | 0.41 |
| Revenue Per Share | 64.83 | 42.66 | 29.69 | 25.44 | 17.66 |
| Net Income Per Share | 0.46 | 0.90 | 1.30 | 1.00 | 1.57 |
| Tax Burden | 0.57 | 0.53 | 0.68 | 0.52 | 0.89 |
| Interest Burden | 0.44 | 0.71 | 0.85 | 0.92 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.08 | 0.08 | 0.07 | 0.08 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
| Income Quality | 4.76 | 1.05 | 1.18 | 1.80 | 1.53 |
Currency in USD
